Symbols

JNJ

Johnson & Johnson·NYSE

--(--)

Signals Analysis

Bullish signal 3

Bearish signal 2

Dividend Aristocrat

High Gross Profit Margin

High Cash/net Profit Ratio

EPS Below Expectations

Revenue Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About JNJ

Johnson & Johnson

The world's largest, most diversified healthcare products company

Industry

Pharmaceutical

Established Date

Listing Date

09/25/1944

Exchange

New York Stock Exchange

Full-time Employees

138,200

Fiscal Year Ends

12-31

Website

www.jnj.com

Security Type

Common stock

Office address

One Johnson & Johnson Plaza, New Brunswick, New Jersey 08933

Business

R & D, manufacture and sale of healthcare products

Introduction

Johnson & Johnson, incorporated in New Jersey in 1887, is a global leader in healthcare. The company focuses on researching, developing, manufacturing and selling a wide range of healthcare products with an emphasis on human health and well-being. Johnson & Johnson operates through two main business units: innovative drugs and medical technology.

Company Financials

EPS

JNJ has released its 2025 Q4 earnings. EPS was reported at 2.46, versus the expected 2.46, meeting expectations. The chart below visualizes how JNJ has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

JNJ has released its 2025 Q4 earnings report, with revenue of 24.56B, reflecting a YoY change of 9.08%, and net profit of 5.12B, showing a YoY change of 49.11%. The Sankey diagram below clearly presents JNJ's revenue sources and cost distribution.